Garetosmab
Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44. Garetosmab has potential anti-cancer activity and can be used to study ossifying fibrous dysplasia (FOP) and cancer.
Product Specifications
CAS Number
2097125-54-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TGF-beta/Smad
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FY-AB44685-01 1 mL
Anti-Serum/Glucocorticoid Regulated Kinase 3 (SGK3)
Sign In for Pricing
View Details FY-AB44685-02 100 µL
Anti-Serum/Glucocorticoid Regulated Kinase 3 (SGK3)
Sign In for Pricing
View Details FY-AB44685-03 200 µL
Anti-Serum/Glucocorticoid Regulated Kinase 3 (SGK3)
Sign In for Pricing
View Details 
RC209127L1V 200 µL
FOXL2 (NM_023067) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 